SHL — Sonic Healthcare Income Statement
0.000.00%
- AU$11.09bn
- AU$15.74bn
- AU$9.65bn
- 87
- 79
- 55
- 85
Annual income statement for Sonic Healthcare, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 8,754 | 9,340 | 8,169 | 8,967 | 9,645 |
| Cost of Revenue | |||||
| Gross Profit | 7,137 | 7,736 | 6,889 | 7,516 | 8,084 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 6,833 | 7,183 | 7,151 | 8,085 | 8,714 |
| Operating Profit | 1,921 | 2,157 | 1,018 | 882 | 931 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 1,829 | 2,077 | 931 | 731 | 751 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 1,348 | 1,515 | 708 | 544 | 544 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 1,315 | 1,461 | 685 | 511 | 514 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 1,315 | 1,461 | 685 | 511 | 514 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 2.74 | 3.03 | 1.45 | 1.04 | 1.07 |
| Dividends per Share |